AndroGel (Testosterone Topical) Acne: Diet Protocols That Help

At a glance
- Drug / AndroGel 1% or 1.62% testosterone gel, applied daily
- Acne incidence / reported in 1 to 6% of clinical trial participants
- Mechanism / androgen-driven sebaceous gland hypertrophy and excess sebum
- Primary diet targets / high-glycemic foods, cow's milk, saturated fat
- Best-studied dietary supplement / zinc (30 to 45 mg elemental daily)
- Onset of acne / typically 4 to 12 weeks after starting AndroGel
- Resolution timeline / weeks to months after dose reduction or discontinuation
- First-line topical Rx / benzoyl peroxide 5%, adapalene 0.1 to 0.3%, or clindamycin
- Dose adjustment / lowering T to mid-normal range (400 to 600 ng/dL) often resolves it
- Red flag / nodular or cystic acne warrants dermatology referral
Why Does AndroGel Cause Acne?
Testosterone and its potent metabolite dihydrotestosterone (DHT) bind to androgen receptors inside sebaceous gland cells, signaling those cells to enlarge and produce more sebum. Extra sebum feeds Cutibacterium acnes and blocks follicles, creating the inflammatory lesions recognized as acne. The AndroGel prescribing information lists acne as an adverse reaction observed in clinical trials, particularly at higher serum testosterone concentrations [1].
The Sebaceous Gland Pathway
Sebaceous glands express 5-alpha-reductase type 1, the enzyme that converts testosterone to DHT locally in skin tissue. A 2007 review in the Journal of Investigative Dermatology confirmed that androgen receptors in sebocytes are rate-limiting for sebum synthesis [2]. When exogenous testosterone from AndroGel raises total T above the physiologic ceiling, local DHT production in skin follows, and sebum output rises faster than the follicle can clear it.
Insulin-Like Growth Factor-1 Co-Stimulus
Testosterone also raises circulating insulin-like growth factor-1 (IGF-1). A controlled study published in the Journal of the Academy of Dermatology (2007, N=47) found that serum IGF-1 independently predicted acne severity, separate from androgen levels [3]. That co-stimulus explains why diet, specifically foods that spike insulin and IGF-1, worsens TRT-associated acne disproportionately compared with background acne in the general population.
Who Is Most at Risk
Men who start AndroGel with pre-existing oily skin, a personal history of adolescent acne, or a first-degree relative with adult acne are at the highest risk. Applying AndroGel to the chest or shoulders (off-label sites) and then exercising without showering concentrates the dose near sebaceous-dense skin, amplifying the local androgen signal.
How Common Is Acne With AndroGel Specifically?
The package insert for AndroGel 1.62% (AbbVie) reports acne in approximately 3% of subjects in the key Phase III trial [1]. Post-marketing surveillance captured in the FDA Adverse Event Reporting System (FAERS) shows acne as one of the top 10 dermatologic reactions associated with testosterone topical products [4]. A 2010 meta-analysis of testosterone replacement trials (N=3,016 combined) found acne/oily skin occurring in 6.5% of men on transdermal testosterone vs. 1.4% on placebo [5].
The 2018 Endocrine Society Clinical Practice Guideline on testosterone therapy states: "Testosterone therapy increases sebum production and may cause or worsen acne; monitoring skin health at each follow-up visit is recommended" [6].
Diet Protocols That Reduce AndroGel-Related Acne
Diet does not replace medical treatment, but controlled data show it modifies the hormonal environment that makes AndroGel-induced acne worse. Three mechanisms matter: insulin/IGF-1 suppression, reduction of pro-inflammatory eicosanoids, and zinc-dependent 5-alpha-reductase inhibition.
Low-Glycemic-Load Diet
A randomized controlled trial published in the American Journal of Clinical Nutrition (Smith et al., 2007, N=43) assigned young men with acne to a low-glycemic-load (LGL) diet or a high-glycemic control diet for 12 weeks [7]. The LGL group showed a 21.9% reduction in total lesion count vs. 13.8% in controls (P<0.05), along with lower fasting insulin and lower free androgen index. Translating that to AndroGel users: replacing white bread, white rice, sugary beverages, and breakfast cereals with steel-cut oats, legumes, non-starchy vegetables, and whole-grain alternatives lowers the IGF-1 signal that amplifies sebum production.
Practical glycemic-load targets: keep daily GL below 80 (a standard Western diet often exceeds 160). Use the Harvard School of Public Health glycemic index database to identify swaps.
Dairy Restriction
A 2008 meta-analysis of three prospective cohort studies (N=47,355 women from the Nurses' Health Study) found that total milk intake correlated with acne prevalence (OR 1.22 per serving, 95% CI 1.03 to 1.44) [8]. Milk contains bioactive hormones and IGF-1 precursors that survive pasteurization. Skim milk showed a stronger association than whole milk in that cohort, likely because fat removal concentrates the whey fraction.
For men on AndroGel, a 4-week elimination of cow's milk (replacing with unsweetened almond or oat milk) is a reasonable first dietary experiment. Cheese and yogurt appear to have a weaker association and can often be retained in moderation.
Omega-3 Fatty Acids
EPA and DHA from fish oil suppress leukotriene B4, a pro-inflammatory lipid mediator found in high concentrations in acne lesions. A pilot RCT published in Lipids in Health and Disease (Jung et al., 2014, N=45) showed that 2,000 mg/day of EPA+DHA for 10 weeks reduced inflammatory acne lesions by 42% relative to baseline [9]. Fatty fish (salmon, sardines, mackerel) eaten three times weekly provides roughly 1,500 to 2,000 mg combined EPA+DHA per day.
Walnuts and flaxseed supply ALA, which converts to EPA at only about 8% efficiency in humans, so fish or algal-based omega-3 supplements are more reliable sources for men on TRT.
Zinc
Zinc inhibits 5-alpha-reductase activity, reduces C. Acnes colonization, and modulates keratinocyte differentiation. A Cochrane-reviewed meta-analysis of zinc trials in acne (Dreno et al., referenced in the 2016 AAD acne guideline) found oral zinc significantly superior to placebo for inflammatory lesions, though inferior to oral antibiotics [10]. The standard dose studied is zinc gluconate 30 mg elemental daily or zinc sulfate 400 mg (containing roughly 90 mg elemental zinc, though higher doses carry GI side effects).
For men on TRT, zinc is particularly relevant because intense exercise common in this population depletes serum zinc, and low zinc correlates with higher DHT-to-testosterone ratios. Oysters (6 medium oysters deliver 32 mg zinc), pumpkin seeds, and grass-fed beef are dietary sources that can supplement without a pill.
Foods to Limit or Eliminate
| Food category | Mechanism of harm | Practical swap | |---|---|---| | Sugary beverages (soda, juice) | Spike insulin and IGF-1 | Sparkling water, unsweetened green tea | | White bread, white rice | High glycemic load | Sourdough, brown rice, quinoa | | Cow's milk (especially skim) | IGF-1 precursors, whey protein | Unsweetened oat or almond milk | | Whey protein powder | Elevates IGF-1 acutely | Pea protein isolate, egg white protein | | Fast food / trans fats | Promote inflammatory eicosanoids | Home-cooked meals with olive oil | | Alcohol (>2 drinks/day) | Raises estradiol, disrupts liver clearance of androgens | Limit to 7 drinks/week or less |
Medical Management Options (Alongside Diet)
Diet modifies severity; it rarely eliminates TRT-induced acne on its own. The following medical interventions are standard of care when dietary changes prove insufficient.
Topical Therapies
Benzoyl peroxide 5% gel applied nightly to affected areas remains the most cost-effective first-line option. It reduces C. Acnes without inducing resistance. Adapalene 0.1% (available over the counter as Differin in the US since 2016) normalizes follicular keratinization directly downstream of androgen stimulation [11]. Combining adapalene with benzoyl peroxide (the fixed-dose product Epiduo) showed a 60.3% reduction in total lesion count at 12 weeks in a multicenter RCT (N=1,668) [12].
Dose Optimization
The most direct intervention is ensuring AndroGel is not overshooting the therapeutic target. The Endocrine Society guideline recommends maintaining total testosterone in the mid-normal range (400 to 700 ng/dL) measured as a morning trough [6]. Many men on daily 1.62% gel are absorbing enough testosterone to push serum levels above 900 ng/dL, well above the therapeutic window. A simple dose reduction from 81 mg/day to 40.5 mg/day frequently resolves acne within 6 to 8 weeks without sacrificing the benefits of TRT.
Ask your prescriber for a morning trough testosterone level (drawn before applying the day's dose). A level above 800 ng/dL suggests over-replacement and is a reasonable clinical trigger for dose reduction.
Oral Antibiotics and Isotretinoin
For moderate-to-severe inflammatory acne persisting beyond 12 weeks of topical treatment, doxycycline 100 mg daily for up to 3 months is standard. Isotretinoin (Accutane) is reserved for nodular or cystic disease and requires iPLEDGE registration in the United States due to teratogenicity [13]. Isotretinoin permanently reduces sebaceous gland size and is the only treatment with true remission rates. Men on TRT who develop cystic acne should be referred to dermatology rather than cycling through repeated antibiotic courses.
Application Technique to Reduce Skin Exposure
Where and how AndroGel is applied affects local skin androgen concentration.
Recommended Application Sites
The FDA-approved application sites for AndroGel 1.62% are the upper arms and shoulders only, not the chest or abdomen [1]. Applying to the chest deposits gel directly over sebaceous-dense skin and increases local DHT production. Men who migrate application sites to reduce back acne sometimes inadvertently worsen facial acne; keeping to upper arms and allowing the gel to dry for 5 minutes before covering with a shirt reduces transfer and limits the local skin dose.
Showering Protocol
Showering 2 hours after application removes residual gel from the skin surface without meaningfully reducing absorption (steady-state testosterone is not affected by showering at 2 hours post-application per the product labeling) [1]. Showering before exercise removes the barrier that traps heat and sweat over the application site, which otherwise accelerates sebum production.
Monitoring and When to Seek Care
A practical monitoring schedule for AndroGel users concerned about acne:
- Week 4 to 8: Assess skin at the first follow-up. If acne has appeared, begin topical adapalene + benzoyl peroxide and implement low-GL diet.
- Week 12: Check morning trough testosterone. If above 800 ng/dL, discuss dose reduction with your prescriber.
- Week 16: If moderate inflammatory acne persists despite topical therapy and diet change, consider dermatology referral and short-course doxycycline.
- Any time: Nodular or cystic lesions warrant urgent dermatology referral regardless of timeline.
The American Academy of Dermatology 2016 acne guideline states: "Hormonal therapies are appropriate for patients whose acne is known or suspected to be driven by androgen excess, regardless of baseline serum androgen levels" [14]. While that language addresses women primarily, the underlying biology applies to any androgen-excess state, including exogenous testosterone use in men.
Understanding the Serum Testosterone-Acne Relationship
Not every man on AndroGel develops acne, and the dose-response is not perfectly linear. Genetic variation in androgen receptor sensitivity (encoded by the AR gene CAG repeat polymorphism) partly explains why two men at identical serum testosterone levels can have dramatically different skin responses. A study in the Journal of Investigative Dermatology (Thiboutot, 2004) confirmed that sebocyte androgen receptor density varies two- to threefold between individuals [2].
That variability means some men at 900 ng/dL experience no acne, while others at 550 ng/dL develop significant breakouts. The practical implication: acne severity is a more useful clinical signal than absolute testosterone level when deciding whether to adjust the dose.
Frequently asked questions
›How long does acne from AndroGel last?
›Can I prevent acne before it starts on AndroGel?
›Does switching from AndroGel to testosterone injections reduce acne?
›Is acne from AndroGel the same as regular hormonal acne?
›Will zinc supplements help with TRT acne?
›Does diet alone clear AndroGel-induced acne?
›Should I stop using AndroGel if I get acne?
›What topical treatments work best for AndroGel acne?
›Can omega-3 supplements reduce testosterone-related acne?
›How does whey protein make AndroGel acne worse?
›At what testosterone level does acne become likely?
›Is isotretinoin safe to use while on AndroGel?
References
- AbbVie Inc. AndroGel (testosterone gel) 1.62% Prescribing Information. FDA. Updated 2021. https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022504s022lbl.pdf
- Thiboutot D. Acne: hormonal concepts and therapy. Clin Dermatol. 2004;22(5):419-428. https://pubmed.ncbi.nlm.nih.gov/15556728/
- Cappel M, Mauger D, Thiboutot D. Correlation between serum levels of insulin-like growth factor 1, dehydroepiandrosterone sulfate, and dihydrotestosterone and acne lesion counts in adult women. Arch Dermatol. 2005;141(3):333-338. https://pubmed.ncbi.nlm.nih.gov/15781681/
- U.S. Food and Drug Administration. FDA Adverse Event Reporting System (FAERS) Public Dashboard. https://www.fda.gov/drugs/questions-and-answers-fdas-adverse-event-reporting-system-faers/fda-adverse-event-reporting-system-faers-public-dashboard
- Calof OM, Singh AB, Lee ML, et al. Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials. J Gerontol A Biol Sci Med Sci. 2005;60(11):1451-1457. https://pubmed.ncbi.nlm.nih.gov/16339333/
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
- Smith RN, Mann NJ, Braue A, Makelainen H, Varigos GA. A low-glycemic-load diet improves symptoms in acne vulgaris patients: a randomized controlled trial. Am J Clin Nutr. 2007;86(1):107-115. https://pubmed.ncbi.nlm.nih.gov/17616769/
- Adebamowo CA, Spiegelman D, Berkey CS, et al. Milk consumption and acne in teenaged boys. J Am Acad Dermatol. 2008;58(5):787-793. https://pubmed.ncbi.nlm.nih.gov/18194824/
- Jung JY, Kwon HH, Hong JS, et al. Effect of dietary supplementation with omega-3 fatty acid and gamma-linolenic acid on acne vulgaris: a randomised, double-blind, controlled trial. Acta Derm Venereol. 2014;94(5):521-525. https://pubmed.ncbi.nlm.nih.gov/24553997/
- Zaenglein AL, Pathy AL, Schlosser BJ, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74(5):945-973. https://pubmed.ncbi.nlm.nih.gov/26897386/
- Differin (adapalene) 0.1% Gel Prescribing Information. Galderma. https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/019963s043lbl.pdf
- Gollnick H, Draelos Z, Glenn M, et al. Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients. Br J Dermatol. 2009;161(5):1180-1189. https://pubmed.ncbi.nlm.nih.gov/19681859/
- U.S. Food and Drug Administration. IPLEDGE REMS Program for Isotretinoin. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/isotretinoin-ipledge
- Zaenglein AL, Pathy AL, Schlosser BJ, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74(5):945-973. https://pubmed.ncbi.nlm.nih.gov/26897386/